BioSpace News Archive

Company Also Receives European CE Mark Approval for Novel Stroke Technology Designed for Difficult to Extract Blood Clots

Sensor networks capture critical atmospheric, climate, and weather data to comprehensively understand air quality

OncoSec Medical Incorporated announced today that the Company has received a $7.0 million investment at $1.50 per share from Alpha Holdings, Inc. (kosdaq:117670) as part of a fundamental strategic investment centered on the clinical development of OncoSec’s lead immunotherapy product candidate, TAVO™ (tavokinogene telseplasmid).

The FCS Foundation, the nation’s leading advocacy and support organization for people affected by familial chylomicronemia syndrome (FCS), today announced the launch of a new national campaign to build broader awareness of the need for a treatment for FCS and to encourage regulators and leaders in research to work to bring a treatment to patients as quickly as possible.

ORHub, Inc. today announces that Blake Stock, Senior Director of Product will present at the AORN of Seattle’s Annual Multi-chapter Conference on Saturday, January 26, 2019 at 10:50AM PST. The conference is being held at the Valley Medical Center in Renton, Washington.

Cerus Corporation announced today that the American Red Cross has received approval by the U.S. Food and Drug Administration for their first biologics license application for interstate distribution of platelets that have been pathogen-reduced with INTERCEPT Blood Systems.

Bioasis Technologies today announced the appointment of Deborah A. Rathjen, B.Sc. (Hons), Ph.D., MAICD, FTSE, as executive chair of the Bioasis board of directors. Dr. Rathjen was appointed chair of the Bioasis board of directors in March 2018.

0x Genomics today announced the acquisition of Stockholm-based Spatial Transcriptomics, a pioneer in the emerging field of spatial genomics.

The State of Michigan Medical Marihuana Licensing Board unanimously voted today to issue the operational approval of 10 class C cultivation licenses to Green Peak Innovations (GPI)

U.S. ARKRAY, Inc. (ARKRAY) announces partnership with Medline Industries, Inc. The company will distribute the ADAMS A1c HA-8180V fully automated HPLC HbA1c analyzer, AUTION MAX AX-4030 fully automated urine chemistry analyzer and AUTION ELEVEN AE-4022 semi-automated urine chemistry analyzer to Physician Office Laboratories (POL’s).